These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38961454)

  • 1. KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors.
    Kind S; Castillo CP; Schlichter R; Gorbokon N; Lennartz M; Hornsteiner LS; Dwertmann Rico S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Hinsch A; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Wilczak W; Sauter G; Menz A; Jacobsen F
    BMC Cancer; 2024 Jul; 24(1):794. PubMed ID: 38961454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
    Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
    Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
    Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
    Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
    Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
    Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
    J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities.
    Gorbokon N; Baltruschat S; Lennartz M; Luebke AM; Höflmayer D; Kluth M; Hube-Magg C; Hinsch A; Fraune C; Lebok P; Bernreuther C; Sauter G; Marx AH; Simon R; Krech T; Clauditz TS; Jacobsen F; Burandt E; Steurer S; Minner S
    Virchows Arch; 2024 Sep; 485(3):491-507. PubMed ID: 39105782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.
    Zhang CY; Zhu Y; Rui WB; Dai J; Shen ZJ
    Asian J Androl; 2015; 17(1):106-10. PubMed ID: 25219913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.
    Silva LM; Kryza T; Stoll T; Hoogland C; Dong Y; Stephens CR; Hastie ML; Magdolen V; Kleifeld O; Gorman JJ; Clements JA
    Mol Cell Proteomics; 2019 May; 18(5):818-836. PubMed ID: 30705123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
    Walker F; Nicole P; Jallane A; Soosaipillai A; Mosbach V; Oikonomopoulou K; Diamandis EP; Magdolen V; Darmoul D
    Biol Chem; 2014 Sep; 395(9):1075-86. PubMed ID: 25153388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of KLK7 in pancreatic cancer and the effects on the biological behavior of pancreatic cancer cells].
    Zheng SL; Feng MY; Yang G; Xiong GB; Zheng LF; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):391-397. PubMed ID: 29779317
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
    Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
    Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
    Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
    Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors.
    Reiswich V; Gorbokon N; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Wittmer C; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Clauditz T; Krech T
    J Pathol Clin Res; 2021 Nov; 7(6):577-589. PubMed ID: 34363325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
    Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
    APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
    Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
    Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.
    Ramani VC; Kaushal GP; Haun RS
    Biochim Biophys Acta; 2011 Aug; 1813(8):1525-31. PubMed ID: 21616098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.